Biochem/physiol Actions
Harpagoside is an orally available iridoid glycoside and an active component of Harpagophytum extract with cardioprotective effects. Harpagoside is shown to directly bind to and activate ACE2. Allosterically inhibits ACE2 binding to spike protein and reduces viral entry and lessen SARS-CoV-2 infection. Harpagoside was reported to suppress AP-1, IL-6, COX-1/2, c-FOS, NF-ĸB expression and upregulate BMP2 and Wnt signaling pathways.
- UPC:
- 42182411
- Condition:
- New
- HazmatClass:
- No
- MPN:
- SML3425-25MG
- CAS:
- 19210-12-9
akash.verma@cenmed.com
(732) 447-1115





